Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 128

1.

Immune checkpoint markers in gastroenteropancreatic neuroendocrine neoplasia.

Bösch F, Brüwer K, Altendorf-Hofmann A, Auernhammer CJ, Spitzweg C, Westphalen CB, Boeck S, Schubert-Fritschle G, Werner J, Heinemann V, Kirchner T, Angele M, Knösel T.

Endocr Relat Cancer. 2019 Jan 1. pii: ERC-18-0494.R1. doi: 10.1530/ERC-18-0494. [Epub ahead of print]

PMID:
30608901
2.

[Erratum to: Hypothyroidism-when and how to treat?]

Koehler VF, Reincke M, Spitzweg C.

Internist (Berl). 2019 Jan;60(1):108. doi: 10.1007/s00108-018-0520-4. German. No abstract available.

PMID:
30361741
3.

Identification and characterization of myocardial metastases in neuroendocrine tumor patients using 68Ga-DOTATATE PET-CT.

Kunz WG, Eschbach RS, Stahl R, Kazmierczak PM, Bartenstein P, Rominger A, Auernhammer CJ, Spitzweg C, Ricke J, Cyran CC.

Cancer Imaging. 2018 Sep 20;18(1):34. doi: 10.1186/s40644-018-0168-2.

4.

A Novel Approach for Image-Guided 131I Therapy of Pancreatic Ductal Adenocarcinoma Using Mesenchymal Stem Cell-Mediated NIS Gene Delivery.

Schug C, Gupta A, Urnauer S, Steiger K, Cheung PF, Neander C, Savvatakis K, Schmohl KA, Trajkovic-Arsic M, Schwenk N, Schwaiger M, Nelson PJ, Siveke JT, Spitzweg C.

Mol Cancer Res. 2019 Jan;17(1):310-320. doi: 10.1158/1541-7786.MCR-18-0185. Epub 2018 Sep 17.

PMID:
30224540
5.

TGFB1-driven mesenchymal stem cell-mediated NIS gene transfer.

Schug C, Urnauer S, Jaeckel C, Schmohl KA, Tutter M, Steiger K, Schwenk N, Schwaiger M, Wagner E, Nelson PJ, Spitzweg C.

Endocr Relat Cancer. 2019 Jan 1;26(1):89-101. doi: 10.1530/ERC-18-0173.

PMID:
30121623
6.

[Update of the S2k guidelines : Surgical treatment of benign thyroid diseases].

Musholt TJ, Bockisch A, Clerici T, Dotzenrath C, Dralle H, Goretzki PE, Hermann M, Holzer K, Karges W, Krude H, Kussmann J, Lorenz K, Luster M, Niederle B, Nies C, Riss P, Schabram J, Schabram P, Schmid KW, Simon D, Spitzweg C, Steinmüller T, Trupka A, Vorländer C, Weber T, Bartsch DK; Leitliniengruppe der CAEK.

Chirurg. 2018 Sep;89(9):699-709. doi: 10.1007/s00104-018-0653-y. Review. German.

PMID:
29876616
7.

[Hypothyroidism-when and how to treat?]

Koehler VF, Reincke M, Spitzweg C.

Internist (Berl). 2018 Jul;59(7):644-653. doi: 10.1007/s00108-018-0438-x. Review. German. Erratum in: Internist (Berl). 2018 Oct 25;:.

PMID:
29872890
8.

External Beam Radiation Therapy Enhances Mesenchymal Stem Cell-Mediated Sodium-Iodide Symporter Gene Delivery.

Schug C, Sievert W, Urnauer S, Müller AM, Schmohl KA, Wechselberger A, Schwenk N, Lauber K, Schwaiger M, Multhoff G, Wagner E, Nelson PJ, Spitzweg C.

Hum Gene Ther. 2018 Nov;29(11):1287-1300. doi: 10.1089/hum.2018.025. Epub 2018 May 3.

PMID:
29724129
9.

[Differentiated thyroid cancer - is less (therapy) more?]

Todica A, Ladurner R, Spitzweg C.

Dtsch Med Wochenschr. 2018 Apr;143(7):453-458. doi: 10.1055/s-0044-102192. Epub 2018 Apr 3. German.

PMID:
29614533
10.

Tropomyosin receptor kinase: a novel target in screened neuroendocrine tumors.

Aristizabal Prada ET, Heinzle V, Knösel T, Nölting S, Spöttl G, Maurer J, Spitzweg C, Angele M, Schmidt N, Beuschlein F, Stalla GK, Blaser R, Kuhn KA, Auernhammer CJ.

Endocr Relat Cancer. 2018 May;25(5):547-560. doi: 10.1530/ERC-17-0201. Epub 2018 Mar 21.

PMID:
29563190
11.

Supportive therapy in gastroenteropancreatic neuroendocrine tumors: Often forgotten but important.

Jin XF, Spampatti MP, Spitzweg C, Auernhammer CJ.

Rev Endocr Metab Disord. 2018 Jun;19(2):145-158. doi: 10.1007/s11154-018-9443-6. Review.

PMID:
29464446
12.

Advanced neuroendocrine tumours of the small intestine and pancreas: clinical developments, controversies, and future strategies.

Auernhammer CJ, Spitzweg C, Angele MK, Boeck S, Grossman A, Nölting S, Ilhan H, Knösel T, Mayerle J, Reincke M, Bartenstein P.

Lancet Diabetes Endocrinol. 2018 May;6(5):404-415. doi: 10.1016/S2213-8587(17)30401-1. Epub 2017 Dec 8. Review.

PMID:
29229497
13.

EGFR-targeted nonviral NIS gene transfer for bioimaging and therapy of disseminated colon cancer metastases.

Urnauer S, Müller AM, Schug C, Schmohl KA, Tutter M, Schwenk N, Rödl W, Morys S, Ingrisch M, Bertram J, Bartenstein P, Clevert DA, Wagner E, Spitzweg C.

Oncotarget. 2017 Sep 16;8(54):92195-92208. doi: 10.18632/oncotarget.21028. eCollection 2017 Nov 3.

14.

Reintroducing the Sodium-Iodide Symporter to Anaplastic Thyroid Carcinoma.

Schmohl KA, Dolp P, Schug C, Knoop K, Klutz K, Schwenk N, Bartenstein P, Nelson PJ, Ogris M, Wagner E, Spitzweg C.

Thyroid. 2017 Dec;27(12):1534-1543. doi: 10.1089/thy.2017.0290. Epub 2017 Nov 10.

PMID:
29032724
15.

[Thyroid emergencies : Thyroid storm and myxedema coma].

Spitzweg C, Reincke M, Gärtner R.

Internist (Berl). 2017 Oct;58(10):1011-1019. doi: 10.1007/s00108-017-0306-0. Review. German.

PMID:
28939923
16.

EGFR Targeting and Shielding of pDNA Lipopolyplexes via Bivalent Attachment of a Sequence-Defined PEG Agent.

Morys S, Urnauer S, Spitzweg C, Wagner E.

Macromol Biosci. 2018 Jan;18(1). doi: 10.1002/mabi.201700203. Epub 2017 Sep 6.

PMID:
28877405
17.

Outcome after resection of Adrenocortical Carcinoma liver metastases: a retrospective study.

Baur J, Büntemeyer TO, Megerle F, Deutschbein T, Spitzweg C, Quinkler M, Nawroth P, Kroiss M, Germer CT, Fassnacht M, Steger U; German Adrenocortical Carcinoma Study Group.

BMC Cancer. 2017 Aug 4;17(1):522. doi: 10.1186/s12885-017-3506-z.

18.

Systemic tumor-targeted sodium iodide symporter (NIS) gene therapy of hepatocellular carcinoma mediated by B6 peptide polyplexes.

Urnauer S, Klutz K, Grünwald GK, Morys S, Schwenk N, Zach C, Gildehaus FJ, Rödl W, Ogris M, Wagner E, Spitzweg C.

J Gene Med. 2017 May;19(5). doi: 10.1002/jgm.2957.

PMID:
28423213
19.

Increased trace amine-associated receptor 1 (TAAR1) expression is associated with a positive survival rate in patients with breast cancer.

Vattai A, Akyol E, Kuhn C, Hofmann S, Heidegger H, von Koch F, Hermelink K, Wuerstlein R, Harbeck N, Mayr D, Spitzweg C, Toth B, Mahner S, Jeschke U, Ditsch N.

J Cancer Res Clin Oncol. 2017 Sep;143(9):1637-1647. doi: 10.1007/s00432-017-2420-8. Epub 2017 Apr 13.

PMID:
28409272
20.

Imaging and targeted therapy of pancreatic ductal adenocarcinoma using the theranostic sodium iodide symporter (NIS) gene.

Schmohl KA, Gupta A, Grünwald GK, Trajkovic-Arsic M, Klutz K, Braren R, Schwaiger M, Nelson PJ, Ogris M, Wagner E, Siveke JT, Spitzweg C.

Oncotarget. 2017 May 16;8(20):33393-33404. doi: 10.18632/oncotarget.16499.

21.

Clinical presentation, treatment and outcome of anaplastic thyroid carcinoma: results of a multicenter study in Germany.

Wendler J, Kroiss M, Gast K, Kreissl MC, Allelein S, Lichtenauer U, Blaser R, Spitzweg C, Fassnacht M, Schott M, Führer D, Tiedje V.

Eur J Endocrinol. 2016 Dec;175(6):521-529.

PMID:
27926471
22.

Leveraging the immune system to treat advanced thyroid cancers.

French JD, Bible K, Spitzweg C, Haugen BR, Ryder M.

Lancet Diabetes Endocrinol. 2017 Jun;5(6):469-481. doi: 10.1016/S2213-8587(16)30277-7. Epub 2016 Oct 20. Review.

PMID:
27773653
23.

Hypoxia-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated sodium iodide symporter gene delivery.

Müller AM, Schmohl KA, Knoop K, Schug C, Urnauer S, Hagenhoff A, Clevert DA, Ingrisch M, Niess H, Carlsen J, Zach C, Wagner E, Bartenstein P, Nelson PJ, Spitzweg C.

Oncotarget. 2016 Aug 23;7(34):54795-54810. doi: 10.18632/oncotarget.10758.

24.

The added value of 68Ga-DOTA-TATE-PET to contrast-enhanced CT for primary site detection in CUP of neuroendocrine origin.

Kazmierczak PM, Rominger A, Wenter V, Spitzweg C, Auernhammer C, Angele MK, Rist C, Cyran CC.

Eur Radiol. 2017 Apr;27(4):1676-1684. doi: 10.1007/s00330-016-4475-3. Epub 2016 Jul 19.

PMID:
27436022
25.

Fine Needle Aspiration in the Investigation of Thyroid Nodules.

Feldkamp J, Führer D, Luster M, Musholt TJ, Spitzweg C, Schott M.

Dtsch Arztebl Int. 2016 May 20;113(20):353-9. doi: 10.3238/arztebl.2016.0353. Review.

26.

Harnessing mesenchymal stem cell homing as an anticancer therapy.

Hagenhoff A, Bruns CJ, Zhao Y, von Lüttichau I, Niess H, Spitzweg C, Nelson PJ.

Expert Opin Biol Ther. 2016 Sep;16(9):1079-92. doi: 10.1080/14712598.2016.1196179. Epub 2016 Jun 13. Review.

PMID:
27270211
27.

New drugs for medullary thyroid cancer: new promises?

Spitzweg C, Morris JC, Bible KC.

Endocr Relat Cancer. 2016 Jun;23(6):R287-97. doi: 10.1530/ERC-16-0104. Epub 2016 May 16. Review.

PMID:
27185870
28.

Sequence-defined cMET/HGFR-targeted Polymers as Gene Delivery Vehicles for the Theranostic Sodium Iodide Symporter (NIS) Gene.

Urnauer S, Morys S, Krhac Levacic A, Müller AM, Schug C, Schmohl KA, Schwenk N, Zach C, Carlsen J, Bartenstein P, Wagner E, Spitzweg C.

Mol Ther. 2016 Aug;24(8):1395-404. doi: 10.1038/mt.2016.95. Epub 2016 May 9.

29.

Establishment of an Effective Radioiodide Thyroid Ablation Protocol in Mice.

Schmohl KA, Müller AM, Schwenk N, Knoop K, Rijntjes E, Köhrle J, Heuer H, Bartenstein P, Göke B, Nelson PJ, Spitzweg C.

Eur Thyroid J. 2015 Sep;4(Suppl 1):74-80. doi: 10.1159/000381019. Epub 2015 May 23.

30.

Life-threatening events in patients with pheochromocytoma.

Riester A, Weismann D, Quinkler M, Lichtenauer UD, Sommerey S, Halbritter R, Penning R, Spitzweg C, Schopohl J, Beuschlein F, Reincke M.

Eur J Endocrinol. 2015 Dec;173(6):757-64. doi: 10.1530/EJE-15-0483. Epub 2015 Sep 7.

PMID:
26346138
31.

Thyroid hormones and tetrac: new regulators of tumour stroma formation via integrin αvβ3.

Schmohl KA, Müller AM, Wechselberger A, Rühland S, Salb N, Schwenk N, Heuer H, Carlsen J, Göke B, Nelson PJ, Spitzweg C.

Endocr Relat Cancer. 2015 Dec;22(6):941-52. doi: 10.1530/ERC-15-0245. Epub 2015 Aug 25.

PMID:
26307023
32.

(124)I-PET Assessment of Human Sodium Iodide Symporter Reporter Gene Activity for Highly Sensitive In Vivo Monitoring of Teratoma Formation in Mice.

Lehner S, Lang C, Kaissis G, Todica A, Zacherl MJ, Boening G, Spitzweg C, Herbach N, Franz WM, Krause BJ, Steinhoff G, Bartenstein P, Hacker M, David R.

Mol Imaging Biol. 2015 Dec;17(6):874-83. doi: 10.1007/s11307-015-0857-1.

PMID:
25896817
33.

Quantification of in vitro mesenchymal stem cell invasion into tumor spheroids using selective plane illumination microscopy.

Rühland S, Wechselberger A, Spitzweg C, Huss R, Nelson PJ, Harz H.

J Biomed Opt. 2015 Apr;20(4):040501. doi: 10.1117/1.JBO.20.4.040501.

PMID:
25839427
34.

Mesenchymal stem cell-mediated, tumor stroma-targeted radioiodine therapy of metastatic colon cancer using the sodium iodide symporter as theranostic gene.

Knoop K, Schwenk N, Schmohl K, Müller A, Zach C, Cyran C, Carlsen J, Böning G, Bartenstein P, Göke B, Wagner E, Nelson PJ, Spitzweg C.

J Nucl Med. 2015 Apr;56(4):600-6. doi: 10.2967/jnumed.114.146662. Epub 2015 Mar 5.

35.

[Advanced radioiodine-refractory differentiated thyroid cancer].

Spitzweg C, Auernhammer CJ, Geisler J, Böck S, Heinemann V, Bartenstein P, Göke B.

Dtsch Med Wochenschr. 2015 Feb;140(3):168-71. doi: 10.1055/s-0041-100196. Epub 2015 Feb 6. Review. German. No abstract available.

PMID:
25658401
36.

[Thyroid dysfunction in pregnancy].

Führer D, Mann K, Feldkamp J, Krude H, Spitzweg C, Kratzsch J, Schott M.

Dtsch Med Wochenschr. 2014 Oct;139(42):2148-52. doi: 10.1055/s-0034-1387300. Epub 2014 Oct 7. Review. German.

PMID:
25289925
37.

Impact of (68)Ga-DOTATATE PET/CT on the surgical management of primary neuroendocrine tumors of the pancreas or ileum.

Ilhan H, Fendler WP, Cyran CC, Spitzweg C, Auernhammer CJ, Gildehaus FJ, Bartenstein P, Angele MK, Haug AR.

Ann Surg Oncol. 2015 Jan;22(1):164-71. doi: 10.1245/s10434-014-3981-2. Epub 2014 Sep 5.

PMID:
25190113
38.

Best supportive care from the conservative/non-surgical perspective and its costs in the treatment of patients with advanced medullary thyroid cancer: results of a Delphi panel.

Kreissl MC, Jacob C, Führer D, Karges W, Luster M, Lux MP, Mann K, Mittendorf T, Schott M, Spitzweg C, Schmoll HJ.

Oncol Res Treat. 2014;37(6):316-22. doi: 10.1159/000362613. Epub 2014 May 12.

PMID:
24903762
39.

Advanced radioiodine-refractory differentiated thyroid cancer: the sodium iodide symporter and other emerging therapeutic targets.

Spitzweg C, Bible KC, Hofbauer LC, Morris JC.

Lancet Diabetes Endocrinol. 2014 Oct;2(10):830-42. doi: 10.1016/S2213-8587(14)70051-8. Epub 2014 Jun 2. Review.

PMID:
24898835
40.

Neuroendocrine tumors of the bronchopulmonary system (typical and atypical carcinoid tumors): current strategies in diagnosis and treatment. Conclusions of an expert meeting February 2011 in Weimar, Germany.

Hörsch D, Schmid KW, Anlauf M, Darwiche K, Denecke T, Baum RP, Spitzweg C, Grohé C, Presselt N, Stremmel C, Heigener DF, Serke M, Kegel T, Pavel M, Waller CF, Deppermann KM, Arnold R, Huber RM, Weber MM, Hoffmann H.

Oncol Res Treat. 2014;37(5):266-76. doi: 10.1159/000362430. Epub 2014 Apr 14. Review.

PMID:
24853787
41.

Treatment with octreotide in patients with well-differentiated neuroendocrine tumors of the ileum: prognostic stratification with Ga-68-DOTA-TATE positron emission tomography.

Koch W, Auernhammer CJ, Geisler J, Spitzweg C, Cyran CC, Ilhan H, Bartenstein P, Haug AR.

Mol Imaging. 2014;13:1-10.

PMID:
24824963
42.

EGFR-Targeted Adenovirus Dendrimer Coating for Improved Systemic Delivery of the Theranostic NIS Gene.

Grünwald GK, Vetter A, Klutz K, Willhauck MJ, Schwenk N, Senekowitsch-Schmidtke R, Schwaiger M, Zach C, Wagner E, Göke B, Holm PS, Ogris M, Spitzweg C.

Mol Ther Nucleic Acids. 2013 Nov 5;2:e131. doi: 10.1038/mtna.2013.58.

43.

Neuroendocrine tumor recurrence: diagnosis with 68Ga-DOTATATE PET/CT.

Haug AR, Cindea-Drimus R, Auernhammer CJ, Reincke M, Beuschlein F, Wängler B, Uebleis C, Schmidt GP, Spitzweg C, Bartenstein P, Hacker M.

Radiology. 2014 Feb;270(2):517-25. doi: 10.1148/radiol.13122501. Epub 2013 Oct 28.

PMID:
24056402
44.

Systemic image-guided liver cancer radiovirotherapy using dendrimer-coated adenovirus encoding the sodium iodide symporter as theranostic gene.

Grünwald GK, Vetter A, Klutz K, Willhauck MJ, Schwenk N, Senekowitsch-Schmidtke R, Schwaiger M, Zach C, Wagner E, Göke B, Holm PS, Ogris M, Spitzweg C.

J Nucl Med. 2013 Aug;54(8):1450-7. doi: 10.2967/jnumed.112.115493. Epub 2013 Jul 10.

45.

Stromal targeting of sodium iodide symporter using mesenchymal stem cells allows enhanced imaging and therapy of hepatocellular carcinoma.

Knoop K, Schwenk N, Dolp P, Willhauck MJ, Zischek C, Zach C, Hacker M, Göke B, Wagner E, Nelson PJ, Spitzweg C.

Hum Gene Ther. 2013 Mar;24(3):306-16. doi: 10.1089/hum.2012.104.

46.

Adenoviral vectors coated with PAMAM dendrimer conjugates allow CAR independent virus uptake and targeting to the EGF receptor.

Vetter A, Virdi KS, Espenlaub S, Rödl W, Wagner E, Holm PS, Scheu C, Kreppel F, Spitzweg C, Ogris M.

Mol Pharm. 2013 Feb 4;10(2):606-18. doi: 10.1021/mp300366f. Epub 2013 Jan 18.

PMID:
23281933
47.

Sodium iodide symporter (NIS)-mediated radiovirotherapy of hepatocellular cancer using a conditionally replicating adenovirus.

Grünwald GK, Klutz K, Willhauck MJ, Schwenk N, Senekowitsch-Schmidtke R, Schwaiger M, Zach C, Göke B, Holm PS, Spitzweg C.

Gene Ther. 2013 Jun;20(6):625-33. doi: 10.1038/gt.2012.79. Epub 2012 Oct 4.

PMID:
23038026
48.

Subcellular distribution of the sodium iodide symporter in benign and malignant thyroid tissues.

Kollecker I, von Wasielewski R, Langner C, Müller JA, Spitzweg C, Kreipe H, Brabant G.

Thyroid. 2012 May;22(5):529-35. doi: 10.1089/thy.2011.0311.

PMID:
22545753
49.

[Medicinal therapy of metastasized neuroendocrine tumors of the gastroenteropancreatic system.]

Auernhammer CJ, Spitzweg C, Heinemann V, Göke B.

Internist (Berl). 2012 Feb 2. [Epub ahead of print] German.

PMID:
22294240
50.

Chromogranin a as serum marker for gastroenteropancreatic neuroendocrine tumors: a single center experience and literature review.

Nölting S, Kuttner A, Lauseker M, Vogeser M, Haug A, Herrmann KA, Hoffmann JN, Spitzweg C, Göke B, Auernhammer CJ.

Cancers (Basel). 2012 Feb 15;4(1):141-55. doi: 10.3390/cancers4010141.

Supplemental Content

Loading ...
Support Center